Huya Enters Into Strategic Partnership With Ocean University Of China

Huya Bioscience (Huya) has entered into a strategic partnership with the School of Medicine and Pharmacy, Ocean University of China. The agreement is an addition in a series of collaborations that Huya has established with China’s research and development institutions to enable and accelerate the development and commercialisation of novel biopharmaceutical product opportunities originating in China.

The agreement with Ocean University of China provides Huya with rights of first review and negotiation relating to certain novel therapeutic and diagnostic product candidates owned or controlled by the University. In return, Ocean University of China gains access to Huya’s global network of pharmaceutical partners and its expertise in pre-clinical and clinical development.

Michael Newman, executive vice president of Oncology at Huya, said: “We look forward to collaborating with this prestigious university to bring novel biopharmaceutical products to the global marketplace.”

Qiangming Wu, executive dean of School of Medicine and Pharmacy at Ocean University of China, said: “We are pleased to partner with Huya’s expert team to achieve this objective.”